Dimercaptosuccinic Acid (DMSA) 150 mg Slow Release Capsules are a specialized compounded formulation designed to provide a controlled and prolonged release of the active ingredient. This prescription medication is primarily used in the treatment of heavy metal poisoning, lead poisoning, Wilson's Disease, and certain types of kidney disease. DMSA is a potent chelating agent that binds to heavy metals within the body, facilitating their excretion via urine.

The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative formulation ensures the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism also reduces the dosing frequency, thereby improving patient compliance, particularly for medications requiring a controlled and prolonged release profile.

DMSA 150 mg Slow Release Capsules are administered orally, typically once daily. The capsules should be swallowed whole, accompanied by a full glass of water. Adherence to the prescribed medication regimen is crucial, and doses should not be skipped.

Patients taking DMSA 150 mg Slow Release Capsules may experience side effects such as nausea, vomiting, diarrhea, and abdominal pain. It is essential to promptly contact your healthcare provider if any of these side effects occur.

Healthcare providers should note that DMSA 150 mg Slow Release Capsules may interact with other medications, including antacids, antibiotics, and anticonvulsants. Therefore, a comprehensive review of a patient's medication list is necessary prior to prescribing DMSA 150 mg Slow Release Capsules.

If you have any questions or require further information about DMSA 150 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. Our team of compounding pharmacists is equipped with the knowledge and expertise to assist you.

Dimercaptosuccinic Acid 150 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects, reduced dosing frequency, and improved patient compliance for medications requiring a controlled and prolonged release profile.

These capsules may interact with other medications, supplements, or herbal products. It is crucial for patients to inform their healthcare provider of all medications, supplements, and herbal products they are currently taking before starting this medication. Additionally, patients should disclose any allergies or medical conditions that may affect the metabolism of this medication.

Dimercaptosuccinic Acid 150 mg Slow Release Capsules may also interact with certain foods, such as dairy products. Patients are advised to avoid consuming these foods while taking this medication.

This medication is used to treat various disease states, including lead poisoning, Wilson's disease, and cystinuria. It is important to note that it may interact with other medications used to treat these conditions, such as penicillamine, potentially increasing the risk of side effects. Therefore, patients should inform their healthcare provider of all medications they are taking before starting this medication.

Furthermore, Dimercaptosuccinic Acid 150 mg Slow Release Capsules may interact with certain laboratory tests, such as urine tests for lead, potentially interfering with the results. Patients should inform their healthcare provider of any laboratory tests they are undergoing before starting this medication.

If you have any questions about the interactions of Dimercaptosuccinic Acid 150 mg Slow Release Capsules, please consult with your healthcare provider.

Dimercaptosuccinic Acid 150 mg Slow Release Capsules are a specialized formulation designed to treat a range of conditions such as lead poisoning, Wilson's disease, and cystinuria. The active ingredient in these capsules is dimercaptosuccinic acid, a potent chelating agent that has the ability to bind to heavy metals and other toxins present in the body, facilitating their excretion through urine.

What sets these capsules apart is their slow-release formulation. They are designed with Methocel E4M, a type of controlled-release polymer. This innovative design allows for the gradual release of the encapsulated medication over an extended period of time. This slow release ensures a sustained therapeutic effect, providing a more consistent level of medication in the body. This can lead to improved patient compliance, especially for those requiring a controlled and prolonged release profile for their medication.

When taking Dimercaptosuccinic Acid 150 mg Slow Release Capsules, it is crucial to follow the prescribed dosage from your healthcare provider. The capsules should be consumed with food and a sufficient amount of water to aid in proper absorption. Additionally, maintaining a high fluid intake throughout the day is recommended to assist in flushing out the toxins that have been bound by the medication.

If you have any queries or concerns regarding Dimercaptosuccinic Acid 150 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to helping you understand the workings of this medication and how it can assist in managing your specific disease state.

Dimercaptosuccinic Acid 150 mg Slow Release Capsules are a versatile treatment option for a variety of conditions. These capsules are particularly effective in treating heavy metal poisoning, including exposure to copper, iron, and zinc. They are also beneficial in managing certain genetic disorders such as cystinuria and cystinosis, which are characterized by the abnormal transport of certain amino acids.

These capsules can also be used in the treatment of specific types of kidney stones, particularly cystine stones. Cystine stones are a common complication of cystinuria, and the slow release of Dimercaptosuccinic Acid can help manage this condition effectively.

Furthermore, Dimercaptosuccinic Acid 150 mg Slow Release Capsules can be used to treat certain types of anemia, such as sideroblastic anemia. This condition is characterized by the body's inability to incorporate iron into hemoglobin, and the slow release of this medication can help manage the symptoms.

These capsules can also be beneficial in treating certain types of liver disease, such as primary biliary cirrhosis. This is a chronic disease that slowly destroys the bile ducts in the liver, and the slow release of Dimercaptosuccinic Acid can help manage this condition.

Additionally, Dimercaptosuccinic Acid 150 mg Slow Release Capsules can be used to treat certain types of kidney disease, such as Fanconi syndrome. This is a rare disorder that affects the kidney's ability to absorb certain substances, and the slow release of this medication can help manage the symptoms.

Finally, these capsules can also be used to treat certain types of skin disorders, such as erythema nodosum. This is a skin condition that causes red, painful lumps to form beneath the skin, and the slow release of Dimercaptosuccinic Acid can help manage this condition.

If you have any questions about the use of Dimercaptosuccinic Acid 150 mg Slow Release Capsules for any of these conditions, please reach out for further information.